Fasting and Gut Health: What We Know

What "Gut Health" Means Here

"Gut health" can mean at least three different things: gut-microbiome composition and diversity, day-to-day digestive symptoms, and the activity of a diagnosed bowel disease. This page covers the first, in people without a diagnosed bowel condition. Trials of fasting or fasting-mimicking regimens as a treatment for conditions such as Crohn's disease, irritable bowel syndrome, or multiple sclerosis are a separate area and are not summarized here.

What Happens to the Gut Microbiome During Fasting

The systematic-review layer of evidence on this question agrees on one thing clearly: fasting is associated with changes in gut-microbiome composition and diversity, and disagrees on almost everything else, including which bacteria change and whether the changes help, harm, or do nothing for health.

A systematic review of 8 human studies, randomized, quasi-experimental, and pilot designs, covering time-restricted eating, alternate-day fasting, or 5:2, found most studies showed an association between intermittent fasting and gut microbiota richness, diversity, and compositional change, but with substantial heterogeneity: which bacteria changed varied widely study to study. The review's own conclusion: "more research is required to validate these findings and clarify whether the compositional changes might be beneficial to human health" (Paukkonen et al., 2024) [1]. A second systematic review of 7 human studies (4 time-restricted eating, 3 Ramadan fasting) and 9 animal studies found alpha-diversity increased in the human studies but was not associated with improved alpha-diversity in the animal ones; only 2 of the 7 human studies found a beneficial correlation between microbiota change and a metabolic or anthropometric outcome such as HDL cholesterol or BMI, and the review's own conclusion hedges toward diet composition, not fasting timing, as the dominant factor (Pieczyńska-Zając et al., 2024) [2].

The newest review in this set, which graded certainty using GRADE with searches through August 2026, looked specifically at time-restricted eating and gut-microbiota alpha diversity in adults with overweight or obesity: of 5 randomized comparative reports, 3 found no clear between-group change, 1 found a timing-dependent divergence between early and late time-restricted eating, and 1 found increased richness after a 6-hour window. Its own conclusion: "available evidence does not establish either a beneficial effect or an absence of effect" on microbiome alpha diversity. Separately, the review rates the overall certainty of this evidence as very low (Zhai et al., 2026) [3]. Treat this as the single strongest "we don't actually know yet" citation on this page.

Other reviews lean supportive, with their own caveats. A systematic review of 9 longitudinal human studies found changes in 16 bacterial genera in response to intermittent fasting, with some genera associated with weight change and metabolic variables, but its own conclusion states some of the changes "return to their basal state after fasting intervention," meaning they are not durable (Pérez-Gerdel et al., 2023) [4]. A systematic review of 17 studies reports that both alternate-day fasting and time-restricted feeding remodel the gut microbiota, shifting the Firmicutes/Bacteroidetes ratio and increasing Lactobacillus and Akkermansia; its available abstract does not state how many of the 17 included studies were human versus animal, so this page cites it only for the general point that this is a studied phenomenon across the fasting literature, not as a human-specific number (Pinto, Silva, and Souza, 2022) [5]. A systematic review of 31 studies, 20 animal and 11 human, found shifts in beneficial bacteria such as Lactobacillus and Bifidobacterium upon fasting, and specifically that Ramadan fasting raised several taxa linked to health; its own conclusion: "further studies are needed to explore properly the connection" (Angoorani et al., 2021) [6].

Individual Human Trials, in Detail

Metabolic Syndrome and Short-Chain Fatty Acids

An 8-week randomized trial of a "2-day" modified intermittent-fasting protocol (69% fewer calories on fasting days) in 39 adults with metabolic syndrome found significant changes in gut microbiota composition, increased short-chain-fatty-acid production, and lower circulating lipopolysaccharide; the microbiota changes were associated with reduced fat mass, lower oxidative stress, and improved vasodilatory function (Guo et al., 2021) [7]. These are associations in a small trial; the authors describe their findings as "potential mechanistic insights," not a proven causal chain.

Trials With Design Limits

An 8-week randomized trial comparing combined intermittent-fasting-plus-"protein-pacing" against calorie restriction, both matched for total energy, found distinct gut-microbial and metabolomic signatures between groups (Mohr et al., 2024) [8]; see "Authors and funding of the cited studies" below for this trial's sponsor and author ties. A 12-week, two-by-two factorial randomized trial (96 participants) tested a low-carbohydrate diet and time-restricted eating, alone and combined, against isocaloric-restricted feeding; time-restricted eating tended to increase the abundance of probiotic species involved in making short-chain fatty acids, and it also produced more lean-mass loss than the arms without time-restricted eating; both findings belong together (Li et al., 2024) [9]. A randomized trial in adults with obesity compared calorie restriction, intermittent fasting, a ketogenic diet, and an ad-libitum diet, with all four groups also receiving the antibiotic rifaximin in the trial's second month; gut-microbiota diversity increased in the intermittent-fasting and ketogenic-diet groups specifically when diet was combined with rifaximin, but the design cannot isolate how much of that change came from the diet alone (Guevara-Cruz et al., 2024) [11].

A Single-Arm Trial Without a Control Group

A 30-day, single-arm, uncontrolled 16:8 time-restricted-eating trial in 49 participants found increased abundance of Akkermansia (a genus) and Rikenellaceae (a family) that the study's own authors describe as anti-inflammatory bacteria and probiotics, alongside immune-cell changes the authors describe as the microbiome "tending to be younger" (Chen et al., 2024) [10]. With no control group, none of these changes can be attributed to the fasting schedule specifically rather than to the study period, diet composition changes, or regression to the mean.

Fasting-Mimicking Diet and Gut Health

A 46-person randomized trial in healthy adults compared a single 7-day fasting-mimicking diet, in low- and high-protein versions, with a control diet: only the high-protein version improved gut-microbiome diversity relative to control (Burns et al., 2025) [12]. With about 15 people per diet arm and one 7-day period, this suggests, but does not establish, that an FMD's protein content may matter for gut outcomes. See what is a fasting-mimicking diet for the complete trial detail.

What's Animal-Only So Far

Much of the mechanistic "why" story behind fasting and the gut is still animal research, running ahead of what has been confirmed in humans. One review in this set drew on 20 animal and 11 human studies (Angoorani et al., 2021) [6], and another found that the rise in microbial diversity seen in human studies of time-restricted eating and Ramadan fasting was not seen in the animal studies it reviewed, with its authors pointing to diet composition as the main driver (Pieczyńska-Zając et al., 2024) [2].

Two further reviews summarize proposed mechanisms, oxidative stress, gut-barrier integrity, the gut-brain axis, mitochondrial function, by which intermittent fasting might reduce obesity-driven gut dysfunction (Dibra and Jala, 2026) [13], and gut-microbiota-immune-metabolic crosstalk more broadly (Diaz-Garrido et al., 2026) [14]. Both are reviews of proposed mechanism, not new primary data, and neither states a human/animal split for the underlying evidence; this page cites them only for the general biological reasoning they describe, not as a human-specific finding.

Why This Evidence Is Thin

Three features of this literature, taken together, explain why no confident headline is possible yet: samples are small (most individual trials run roughly 39 to 96 participants), durations are short (8 weeks is typical, with some trials shorter), and methods are heterogeneous enough, different fasting protocols, different populations, different sequencing methods, that the newest review in this set judged its studies too different to combine in a meta-analysis (Zhai et al., 2026) [3]. That is a description of the evidence base's current limits, not a prediction about what future, larger trials will find.

Who Should Talk to a Clinician First

Broad cautions apply here as with any fasting approach: talk to a clinician before fasting if you are pregnant, under 18, managing diabetes or blood pressure with medication, or have a history of an eating disorder. If you have a diagnosed bowel condition, such as inflammatory bowel disease or irritable bowel syndrome, involve a gastroenterologist before changing your eating pattern; this page's scope is gut health in people without a diagnosed bowel condition, and its findings should not be read as guidance for managing one.

Safety and Cautions

This is general information, not medical advice. Human research on fasting and the gut microbiome is small, short, and inconsistent; treat any single trial's numbers as evidence to weigh, not a guarantee of your own result. Talk to a clinician before fasting of any kind or length if you are pregnant, under 18, have a history of an eating disorder, manage diabetes or blood pressure with medication, or have a diagnosed bowel condition.